Cowen Inc’s Aerie Pharmaceuticals AERI Stock Holding History

Cowen Inc’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-10,000	Closed	-$526K	–	341
2017 Q2	$526K	Buy	10,000 +9,900	+9,900%	+$461K	0.03%	212
2017 Q1	$454K	Buy	+100	New	+$4.46K	0.02%	176

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cowen Inc's AERI Position: Q3 2015 in Review

Cowen Inc sold out of Aerie Pharmaceuticals (AERI) in Q3 2015, closing a stake of 20,150 shares.

Cowen Inc first reported a position in AERI in Q2 2015 and held it in 1 quarter. The position peaked at $0 in Q2 2015. 115 funds tracked by Wall St. Rank hold AERI as of Q3 2015.

Cowen Inc reported no remaining Aerie Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Cowen Inc sold 20,150 Aerie Pharmaceuticals shares in Q3 2015.
Cowen Inc first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 1 quarter.
Cowen Inc's Aerie Pharmaceuticals position peaked at $0 in Q2 2015.
115 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.